New drug tested for rare genetic brain disorder
NCT ID NCT06717438
Summary
This study is testing whether an investigational drug called zatolmilast is safe and tolerable for people with Jordan's Syndrome, a rare genetic disorder that affects brain development. It involves about 30 participants aged 9 to 45 who have a confirmed diagnosis. The main goal is to check for side effects and see how well the drug is handled by the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JORDAN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Seattle Children's Hospital
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.